boswellia serrata
Botanicalexperimental
Boswellia serrata is a plant that produces Indian frankincense. The plant is native to much of India and the Punjab region that extends into Pakistan. — Wikipedia
Clinical trial activity
17 trials · 24 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
3
Phase 4
2
Earliest trial started Sep 1, 2004 (NCT00243022)
Timeline
Indications
Approved for
Studied for
- Brain Edema · Phase 2
- Brain Neoplasms · Phase 2
- Breast Neoplasms · Phase 4
- Coronavirus Infections · Phase 3
- COVID-19 · Phase 3
- Gastrointestinal Microbiome · Phase 2/Phase 3
- Gulf War · Phase 2
- Kidney Diseases · Phase 1/Phase 2
- Multiple Sclerosis, Relapsing-Remitting · Phase 2
- Osteoarthritis · Phase 4
- Postoperative Pain · Phase 4
- Severe Acute Respiratory Syndrome · Phase 3
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBoswellia serrata ↗
Also known as
- boswellia leaf extract
- boswellia serrata
- boswellia serrata extract
- boswellic acids
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07109843 | N/A | Sep 1, 2025 | Medical University of Graz |
| NCT06969989 | N/A | Jul 1, 2025 | Cairo University |
| NCT05788705 | N/A | Jul 31, 2023 | Assiut University |
| NCT05925725 | Phase 4 | Jan 25, 2023 | Polyclinic of the Hospitaller Brothers of St. John of God, Budapest |
| NCT05570123 | N/A | Sep 14, 2022 | Artialis, Tilman S.A., Universitair Ziekenhuis Gent |
| NCT06466538 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2022 | Mansoura University |
| NCT05150782 | N/A | Jan 17, 2022 | Cognitive Health Platform AG, PhysioMetrics |
| NCT04802382 | Phase 3 | Jun 11, 2021 | MGC Pharmaceuticals |
| NCT05345028 | N/A | Mar 3, 2021 | University of Pavia |
| NCT04669119 | Phase 4 | Dec 31, 2020 | University of Bari |
| NCT03924596 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2019 | Sultan Qaboos University |
| NCT03149081 | Phase 1 | Jul 1, 2017 | Medical University of South Carolina, University of South Carolina |
| NCT02909686 | Phase 2 | Jul 1, 2016 | Department of Defense, University of Alabama, Birmingham |
| NCT02216253 | N/A | Oct 1, 2014 | Vita-Salute University of Milano. Italy |
| NCT01450124 | Phase 2 | Sep 1, 2011 | University of Hamburg |
| NCT00577330 | Phase 3 | May 1, 2006 | ProThera, Inc. |
| NCT00243022 | Phase 2 | Sep 1, 2004 | Case Western Reserve University, National Cancer Institute (NCI), University of Rochester |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (24)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Artialis | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Assiut University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Case Western Reserve University | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Cognitive Health Platform AG | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Department of Defense | Government | 1 | 0 | 1 | 2016 |
| Mansoura University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Medical University of Graz | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Medical University of South Carolina | Academic/Hospital | 1 | 0 | 1 | 2017 |
| MGC Pharmaceuticals | For profit | 1 | 1 | 1 | 2021 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2004 |
| PhysioMetrics | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Polyclinic of the Hospitaller Brothers of St. John of God, Budapest | Academic/Hospital | 1 | 1 | 1 | 2023 |
| ProThera, Inc. | For profit | 1 | 1 | 1 | 2006 |
| Sultan Qaboos University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Tilman S.A. | For profit | 1 | 1 | 1 | 2022 |
| Universitair Ziekenhuis Gent | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Bari | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Hamburg | Academic/Hospital | 1 | 1 | 1 | 2011 |
24 organizations
Page 1 / 2